ketoconazole has been researched along with Aspergillosis in 132 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Aspergillosis: Infections with fungi of the genus ASPERGILLUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Itraconazole, 200 to 400 mg once daily, was administered to 49 patients with different types of aspergillosis: pulmonary aspergilloma (14 patients), chronic necrotizing pulmonary aspergillosis (14), and invasive aspergillosis (21)." | 9.06 | Itraconazole therapy in aspergillosis: study in 49 patients. ( Dupont, B, 1990) |
| "A one year study of the efficacy of the antifungal agent ketoconazole in non-invasive pulmonary aspergillosis was carried out." | 9.06 | Trial of ketoconazole in non-invasive pulmonary aspergillosis. ( Faux, JA; Lane, DJ; Shale, DJ, 1987) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 7.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "This experience suggests itraconazole may be an important advance in the therapy of aspergillosis." | 7.67 | Treatment of invasive aspergillosis with itraconazole. ( Denning, DW; Hanson, LH; Stevens, DA; Tucker, RM, 1989) |
| " The clinical signs of corneal infection disappeared after three (Aspergillus infections) to seven weeks (Fusarium infections) of ketoconazole therapy." | 7.67 | Topical ketoconazole for fungal keratitis. ( Cavazos-Adame, H; Martinez, LA; Mohamed, J; Torres, MA, 1985) |
| "The efficacy of amphotericin B, 5-fluorocytosine and itraconazole was compared for the treatment of experimental rabbit Aspergillus fumigatus endocarditis." | 7.67 | A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit. ( Longman, LP; Martin, MV, 1987) |
| "Fifteen dogs with nasal aspergillosis were treated with ketoconazole (5 mg/kg of body weight, q 12 h, PO) for 2 to 18 weeks." | 7.67 | Use of ketoconazole in the treatment of canine nasal aspergillosis. ( Sharp, NJ; Sullivan, M, 1989) |
| "A patient with longstanding ankylosing spondylitis developed chronic necrotising pulmonary aspergillosis, which was successfully treated with itraconazole." | 7.67 | Chronic necrotising pulmonary aspergillosis treated with itraconazole. ( Cumming, D; Elliott, JA; Milne, LJ, 1989) |
| " Treatment of invasive aspergillosis required a higher dosage (about 5 mg/kg) and prolonged administration." | 5.28 | Experience with itraconazole in cryptococcosis and aspergillosis. ( Almaviva, M; Cristina, S; De Maria, R; Ferrazzi, P; Fiocchi, R; Langer, M; Negri, C; Scoccia, S; Tortorano, AM; Viviani, MA, 1989) |
| "Treatment with amphotericin B resulted in only moderate improvement of the lesions and was accompanied by considerable toxicity." | 5.28 | Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease. ( Raven, EJ; van 't Wout, JW; van der Meer, JW, 1990) |
| "Pretreatment with ketoconazole for 48 hr completely abolished the protective effect of a subsequent therapy with amphotericin B, whether ketoconazole therapy was stopped (P less than ." | 5.27 | The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. ( Frick, PG; Schaffner, A, 1985) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 5.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| " In a neutropenic mouse model, itraconazole appeared to be as effective as amphotericin B against Candida albicans, and was more effective than amphotericin B in treating an Aspergillus infection in a patient with chronic granulomatous disease." | 5.07 | Itraconazole in neutropenic patients. ( van't Wout, JW, 1992) |
| "Itraconazole, 200 to 400 mg once daily, was administered to 49 patients with different types of aspergillosis: pulmonary aspergilloma (14 patients), chronic necrotizing pulmonary aspergillosis (14), and invasive aspergillosis (21)." | 5.06 | Itraconazole therapy in aspergillosis: study in 49 patients. ( Dupont, B, 1990) |
| "A one year study of the efficacy of the antifungal agent ketoconazole in non-invasive pulmonary aspergillosis was carried out." | 5.06 | Trial of ketoconazole in non-invasive pulmonary aspergillosis. ( Faux, JA; Lane, DJ; Shale, DJ, 1987) |
| "5 years developed an elevated serum concentration of digoxin in association with digoxin toxicity (characterized by nausea and vomiting) 9 days after the addition of itraconazole to his regimen for the treatment of sternal osteomyelitis." | 3.68 | Interaction of itraconazole and digoxin. ( Blanchard, LM; Green, PJ; Sachs, MK, 1993) |
| "The triazole Bay R 3783 was compared with fluconazole, itraconazole, ketoconazole, and amphotericin B in rodent models of superficial and systemic candidiasis, meningocerebral cryptococcosis, and pulmonary aspergillosis." | 3.68 | Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. ( Hector, RF; Yee, E, 1990) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 3.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "A patient with longstanding ankylosing spondylitis developed chronic necrotising pulmonary aspergillosis, which was successfully treated with itraconazole." | 3.67 | Chronic necrotising pulmonary aspergillosis treated with itraconazole. ( Cumming, D; Elliott, JA; Milne, LJ, 1989) |
| "This experience suggests itraconazole may be an important advance in the therapy of aspergillosis." | 3.67 | Treatment of invasive aspergillosis with itraconazole. ( Denning, DW; Hanson, LH; Stevens, DA; Tucker, RM, 1989) |
| "Fifteen dogs with nasal aspergillosis were treated with ketoconazole (5 mg/kg of body weight, q 12 h, PO) for 2 to 18 weeks." | 3.67 | Use of ketoconazole in the treatment of canine nasal aspergillosis. ( Sharp, NJ; Sullivan, M, 1989) |
| "Combination pairs of 5-fluorocytosine (5-FC) + itraconazole (Itra), 5-FC + fluconazole (Fluc), and amphotericin B (Amph B) + Itra were administered to mice with experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis with a variety of combination ratios." | 3.67 | Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. ( Polak, A, 1987) |
| " The clinical signs of corneal infection disappeared after three (Aspergillus infections) to seven weeks (Fusarium infections) of ketoconazole therapy." | 3.67 | Topical ketoconazole for fungal keratitis. ( Cavazos-Adame, H; Martinez, LA; Mohamed, J; Torres, MA, 1985) |
| "The efficacy of amphotericin B, 5-fluorocytosine and itraconazole was compared for the treatment of experimental rabbit Aspergillus fumigatus endocarditis." | 3.67 | A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit. ( Longman, LP; Martin, MV, 1987) |
| "Combination pairs of the major systematic antimycotic drugs, amphotericin B (AmphB), 5-fluorocytosine (5-FC) and ketoconazole (Ktz) were administered to mice with experimental candidiasis, cryptococcosis and aspergillosis at a variety of combination ratios." | 3.66 | Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. ( Polak, A; Scholer, HJ; Wall, M, 1982) |
| "I treated seven patients with keratomycosis (four with Candida infections and three with Aspergillus infections) with topical and subconjunctival miconazole." | 3.66 | Miconazole therapy for keratomycosis. ( Foster, CS, 1981) |
| " The extract was as effective as the positive control ketoconazole dosed at 60 mg/kg." | 2.77 | A controlled study to determine the efficacy of Loxostylis alata (Anacardiaceae) in the treatment of aspergillus in a chicken (Gallus domesticus) model in comparison to ketoconazole. ( Duncan, N; Eloff, JN; Naidoo, V; Suleiman, MM, 2012) |
| "Ketoconazole was used in the form of tablets and instillations." | 2.67 | [Imidazoles in the treatment of ocular mycoses]. ( Diadina, UV; Lapshina, NA; Maĭchuk, IuF, 1991) |
| "Zygomycosis is an opportunistic fungal infection that is increasingly reported in hematological patients." | 2.42 | Improved outcome of zygomycosis in patients with hematological diseases? ( Anagnostopolous, I; Gleissner, B; Schilling, A; Siehl, I; Thiel, E, 2004) |
| " The proper duration and dosage and the combination of antifungal drugs have not been clearly defined." | 2.38 | [Primary Aspergillus endocarditis. Apropos of a case and review of the international literature]. ( Cajot, MA; Gosselin, B; Goullard, L; Koussa, A; Marquette, F; Pol, A; Roux, JP; Soots, G; Warembourg, H, 1992) |
| "Invasive fungal infections are common in immunocompromised patients." | 2.38 | [Systemic mycotic infections]. ( Meunier, F, 1990) |
| "The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
| "Mycotic pneumonias are common problems seen in small companion animals because of the wide environmental distribution of fungi and their use of airborne spores for reproduction." | 2.37 | Mycotic pneumonias. ( Roudebush, P, 1985) |
| "flavus eumycetoma confirmed by isolation, molecular identification and immunohistochemical analysis." | 1.42 | Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry. ( Abbas, MA; Ahmed, SA; Al-Hatmi, AM; de Hoog, GS; Jouvion, G; Kolecka, A; Mahgoub, el S, 2015) |
| "Cutaneous aspergillosis is a rare infection most often seen in immunocompromised patients." | 1.37 | Nonhealing scalp wound infected with Aspergillus niger in an elderly patient. ( Fien, S; Grassi, MA; Robinson, A, 2011) |
| "Thymol was an especially potent chemosensitizing agent for amphotericin B, fluconazole or ketoconazole." | 1.35 | Chemosensitization prevents tolerance of Aspergillus fumigatus to antimycotic drugs. ( Campbell, B; Chan, K; Kim, J; Mahoney, N; May, G; Molyneux, R, 2008) |
| "Ketoconazole was used in the first variety and itroconazole in the latter." | 1.32 | Paranasal sinus aspergillosis: its categorization to develop a treatment protocol. ( Balaji, P; Chakrabarti, A; Panda, NK; Reddy, CE; Sharma, SC, 2004) |
| "A 31 years old woman presenting a spinal cord compression due to an aspergilloma." | 1.30 | [Dorsal cord compression by aspergilloma. Apropos of a case]. ( Ba, MC; Badiane, M; Badiane, SB; Gueye, EM; Gueye, M; Ndao, AK; Sakho, Y, 1997) |
| "In its early stage, cranial nerve palsies are caused by nerve compression or invasion by this disease." | 1.28 | [Sphenoid sinus aspergillosis presenting abducens nerve palsy and visual field impairment; a case report]. ( Basugi, N; Eguchi, M; Matsuno, A; Yoshida, S, 1992) |
| " Treatment of invasive aspergillosis required a higher dosage (about 5 mg/kg) and prolonged administration." | 1.28 | Experience with itraconazole in cryptococcosis and aspergillosis. ( Almaviva, M; Cristina, S; De Maria, R; Ferrazzi, P; Fiocchi, R; Langer, M; Negri, C; Scoccia, S; Tortorano, AM; Viviani, MA, 1989) |
| "Treatment with amphotericin B resulted in only moderate improvement of the lesions and was accompanied by considerable toxicity." | 1.28 | Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease. ( Raven, EJ; van 't Wout, JW; van der Meer, JW, 1990) |
| "Invasive fungal infections are becoming increasingly frequent among immunocompromised patients and especially among cancer patients." | 1.27 | Treatment of mycoses in cancer patients. ( Meunier-Carpentier, F, 1983) |
| "BAY N 7133 was also effective for mouse candidosis by parenteral administration and was effective for guinea pig trichophytosis on topical application." | 1.27 | Antimycotic activity of BAY N 7133 in animal experiments. ( Plempel, M, 1984) |
| "A patient with acute myeloid leukemia (AML) who developed probable aspergillosis of the lung underwent partial lobectomy prior to allogeneic bone marrow transplantation (BMT)." | 1.27 | Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung. ( Cohen, O; De Pauw, BE; De Vries, F; De Witte, T; Donnelly, JP; Schattenberg, A, 1988) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 1.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| " One day after challenge, oral treatment with BAY n7133, ketoconazole, or a placebo control was begun BAY n7133 was well absorbed after oral administration and penetrated all tissues evaluated." | 1.27 | Treatment of experimental murine aspergillosis with BAY n7133. ( Drutz, DJ; Graybill, JR; Kaster, SR, 1983) |
| "Pretreatment with ketoconazole for 48 hr completely abolished the protective effect of a subsequent therapy with amphotericin B, whether ketoconazole therapy was stopped (P less than ." | 1.27 | The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. ( Frick, PG; Schaffner, A, 1985) |
| "Ketoconazole also has a therapeutic effect in the reduction of well established A." | 1.26 | Ketoconazole: a new imidazole antifungal agent has both prophylactic potential and therapeutic efficacy in keratomycosis of rabbits. ( Oji, EO, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 48 (36.36) | 18.7374 |
| 1990's | 74 (56.06) | 18.2507 |
| 2000's | 5 (3.79) | 29.6817 |
| 2010's | 5 (3.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kouitcheu, R | 1 |
| Oka, DN | 1 |
| Varlet, G | 1 |
| Ahmed, SA | 1 |
| Abbas, MA | 1 |
| Jouvion, G | 1 |
| Al-Hatmi, AM | 1 |
| de Hoog, GS | 1 |
| Kolecka, A | 1 |
| Mahgoub, el S | 1 |
| Kredics, L | 1 |
| Varga, J | 1 |
| Kocsubé, S | 1 |
| Rajaraman, R | 1 |
| Raghavan, A | 1 |
| Dóczi, I | 1 |
| Bhaskar, M | 1 |
| Németh, TM | 1 |
| Antal, Z | 1 |
| Venkatapathy, N | 1 |
| Vágvölgyi, C | 1 |
| Samson, RA | 1 |
| Chockaiya, M | 1 |
| Palanisamy, M | 1 |
| Nakashima, K | 1 |
| Yamada, N | 1 |
| Yoshida, Y | 1 |
| Yamamoto, O | 1 |
| Robinson, A | 1 |
| Fien, S | 1 |
| Grassi, MA | 1 |
| Suleiman, MM | 1 |
| Duncan, N | 1 |
| Eloff, JN | 1 |
| Naidoo, V | 1 |
| Garg, P | 1 |
| Mahesh, S | 1 |
| Bansal, AK | 1 |
| Gopinathan, U | 1 |
| Rao, GN | 1 |
| Panda, NK | 1 |
| Balaji, P | 1 |
| Chakrabarti, A | 2 |
| Sharma, SC | 1 |
| Reddy, CE | 1 |
| Gleissner, B | 1 |
| Schilling, A | 1 |
| Anagnostopolous, I | 1 |
| Siehl, I | 1 |
| Thiel, E | 1 |
| Kim, J | 1 |
| Campbell, B | 1 |
| Mahoney, N | 1 |
| Chan, K | 1 |
| Molyneux, R | 1 |
| May, G | 1 |
| Quintiliani, R | 1 |
| Owens, NJ | 1 |
| Quercia, RA | 1 |
| Klimek, JJ | 1 |
| Nightingale, CH | 1 |
| Van Cutsem, J | 2 |
| Van Gerven, F | 1 |
| Van de Ven, MA | 1 |
| Borgers, M | 1 |
| Janssen, PA | 1 |
| Farquhar, DL | 1 |
| Munro, JF | 1 |
| Milne, LJ | 2 |
| Piris, J | 1 |
| Foster, CS | 1 |
| Staib, F | 1 |
| Mishra, SK | 1 |
| Böttcher, M | 1 |
| Meunier-Carpentier, F | 2 |
| Oji, EO | 1 |
| Polak, A | 2 |
| Scholer, HJ | 2 |
| Wall, M | 1 |
| Stamm, AM | 1 |
| Dismukes, WE | 1 |
| Horsburgh, CR | 1 |
| Cannady, PB | 1 |
| Kirkpatrick, CH | 1 |
| Gumbart, CH | 1 |
| Graybill, JR | 2 |
| Kaster, SR | 1 |
| Drutz, DJ | 1 |
| Plempel, M | 1 |
| Nong, H | 2 |
| Li, J | 2 |
| Huang, G | 2 |
| Shaw, GS | 1 |
| Ramos, EL | 1 |
| Mouy, R | 2 |
| Veber, F | 1 |
| Blanche, S | 1 |
| Donadieu, J | 1 |
| Brauner, R | 1 |
| Levron, JC | 1 |
| Griscelli, C | 2 |
| Fischer, A | 2 |
| Guleria, R | 2 |
| Gupta, D | 1 |
| Jindal, SK | 1 |
| Sachs, MK | 2 |
| Blanchard, LM | 1 |
| Green, PJ | 1 |
| Moore, L | 1 |
| Ellis, DH | 1 |
| Suppiah, R | 1 |
| Byard, RW | 1 |
| Toogood, IR | 1 |
| Piketty, C | 1 |
| George, F | 1 |
| Weiss, L | 1 |
| Lavarde, V | 1 |
| Hernigou, A | 1 |
| Kazatchkine, MD | 1 |
| Holt, RI | 1 |
| Kwan, JT | 1 |
| Sefton, AM | 1 |
| Cunningham, J | 1 |
| Goldberg, SL | 1 |
| Geha, DJ | 1 |
| Marshall, WF | 1 |
| Inwards, DJ | 1 |
| Hoagland, HC | 1 |
| Trigg, ME | 1 |
| Menezes, AH | 1 |
| Giller, R | 1 |
| Lanza, L | 1 |
| Smith, RJ | 1 |
| Sato, Y | 1 |
| Peters, C | 1 |
| Altman, A | 1 |
| Lortholary, O | 1 |
| Meyohas, MC | 1 |
| Dupont, B | 4 |
| Cadranel, J | 1 |
| Salmon-Ceron, D | 1 |
| Peyramond, D | 1 |
| Simonin, D | 1 |
| Pande, JN | 1 |
| Bryce, GE | 1 |
| Phillips, P | 1 |
| Lepawsky, M | 1 |
| Gribble, MJ | 1 |
| Berry, WL | 1 |
| Leisewitz, AL | 1 |
| Burgaleta, C | 1 |
| Fortun Abete, J | 1 |
| Berenguer Berenguer, J | 1 |
| Romero Maura, JM | 1 |
| Bori Aiguavella, MA | 1 |
| Fontana, M | 1 |
| Escolán Gelos, A | 1 |
| Nong, D | 1 |
| Chen, Z | 1 |
| Ba, MC | 1 |
| Badiane, M | 1 |
| Ndao, AK | 1 |
| Badiane, SB | 1 |
| Sakho, Y | 1 |
| Gueye, EM | 1 |
| Gueye, M | 1 |
| Le Conte, P | 1 |
| Joly, V | 1 |
| Saint-Julien, L | 1 |
| Gillardin, JM | 1 |
| Carbon, C | 1 |
| Yeni, P | 1 |
| Denning, DW | 6 |
| Stepan, DE | 1 |
| Blume, KG | 1 |
| Stevens, DA | 5 |
| Kalin, M | 1 |
| O'Day, DM | 1 |
| Head, WS | 1 |
| Robinson, RD | 1 |
| Williams, TE | 1 |
| Gedde, S | 1 |
| Carlson, AN | 1 |
| Foulks, GN | 1 |
| Perfect, JR | 1 |
| Kim, JH | 1 |
| Schmitt, HJ | 1 |
| Edwards, F | 1 |
| Andrade, J | 1 |
| Niki, Y | 1 |
| Armstrong, D | 1 |
| Roux, JP | 1 |
| Koussa, A | 1 |
| Cajot, MA | 1 |
| Marquette, F | 1 |
| Goullard, L | 1 |
| Gosselin, B | 1 |
| Pol, A | 1 |
| Warembourg, H | 1 |
| Soots, G | 1 |
| van't Wout, JW | 2 |
| Shannon, D | 1 |
| Matsuno, A | 1 |
| Yoshida, S | 1 |
| Basugi, N | 1 |
| Eguchi, M | 1 |
| Azanza, JR | 1 |
| Herreros, J | 1 |
| López-Ocariz, A | 1 |
| Catalán, M | 1 |
| Forbes, NA | 1 |
| Simpson, GN | 1 |
| Goudswaard, MF | 1 |
| Hendriks, WD | 1 |
| Sizoo, W | 1 |
| Durand, F | 1 |
| Bernuau, J | 1 |
| Sauvanet, A | 1 |
| Belghiti, J | 1 |
| Degott, C | 1 |
| Benhamou, JP | 1 |
| Schaberg, T | 1 |
| Lode, H | 1 |
| Kauffman, CA | 1 |
| Bagnasco, FA | 1 |
| Masclans, JR | 1 |
| Pérez, A | 1 |
| Tenorio, L | 1 |
| Planas, M | 1 |
| McGregor, A | 1 |
| McNicol, D | 1 |
| Collignon, P | 1 |
| Crevits, B | 1 |
| Van der Straeten, E | 1 |
| Naeyaert, JM | 1 |
| Van Hecke, E | 1 |
| Kint, A | 1 |
| Georgiev, VS | 1 |
| Cacciapuoti, A | 1 |
| Loebenberg, D | 1 |
| Parmegiani, R | 1 |
| Antonacci, B | 1 |
| Norris, C | 1 |
| Moss, EL | 1 |
| Menzel, F | 1 |
| Yarosh-Tomaine, T | 1 |
| Hare, RS | 1 |
| Miller, GH | 1 |
| Niimi, T | 1 |
| Kajita, M | 1 |
| Saito, H | 1 |
| Ruffin, RE | 1 |
| Bellamy, J | 1 |
| Peters-Christodoulou, MN | 1 |
| de Beer, FC | 1 |
| Bots, GT | 1 |
| Ottenhoff, TM | 1 |
| Thompson, J | 1 |
| van 't Wout, JW | 2 |
| Kramer, MR | 2 |
| Marshall, SE | 2 |
| Ross, DJ | 1 |
| Berry, G | 1 |
| Lewiston, NJ | 2 |
| Theodore, J | 2 |
| Kloss, S | 1 |
| Schuster, A | 1 |
| Schroten, H | 1 |
| Lamprecht, J | 2 |
| Wahn, V | 1 |
| Kamei, K | 1 |
| Kohno, N | 1 |
| Tabeta, H | 1 |
| Honda, A | 1 |
| Unno, H | 1 |
| Nagao, K | 1 |
| Kuriyama, T | 1 |
| Yamaguchi, T | 1 |
| Miyaji, M | 1 |
| Kumar, B | 1 |
| Kaur, I | 1 |
| Sharma, VK | 1 |
| Viviani, MA | 5 |
| Campbell, JH | 1 |
| Winter, JH | 1 |
| Richardson, MD | 1 |
| Shankland, GS | 1 |
| Banham, SW | 1 |
| Gintautiene, K | 1 |
| Lamarca, C | 1 |
| Duvalsaint, F | 1 |
| Chaudhry, MR | 1 |
| Tadoori, P | 1 |
| Abadir, AR | 1 |
| Gintautas, J | 1 |
| Novakova, I | 1 |
| Verhagen, CA | 1 |
| Fibbe, WE | 1 |
| de Pauw, BE | 2 |
| van der Meer, JW | 2 |
| Maĭchuk, IuF | 1 |
| Lapshina, NA | 1 |
| Diadina, UV | 1 |
| Milleron, B | 1 |
| Roger, V | 1 |
| Roux, P | 1 |
| Lebreton, C | 1 |
| Koeger, A | 1 |
| Akoun, G | 1 |
| Paluzzi, RG | 1 |
| Moore, JH | 1 |
| Fraimow, HS | 1 |
| Ost, D | 1 |
| Blomley, M | 1 |
| Teare, EL | 1 |
| de Belder, A | 1 |
| Thway, Y | 1 |
| Weston, M | 1 |
| Singh, SM | 2 |
| Sharma, S | 2 |
| Chatterjee, PK | 2 |
| Coriglione, G | 1 |
| Stella, G | 1 |
| Gafa, L | 1 |
| Spata, G | 1 |
| Oliveri, S | 1 |
| Padhye, AA | 1 |
| Ajello, L | 1 |
| Raven, EJ | 1 |
| Hector, RF | 1 |
| Yee, E | 1 |
| Nussaume, O | 1 |
| Elzaabi, M | 1 |
| Icard, P | 1 |
| Branger, C | 1 |
| Bouttier, S | 1 |
| Andreassian, B | 1 |
| Keogh, AM | 1 |
| Tucker, RM | 3 |
| Galgiani, JN | 1 |
| Kühn, AG | 1 |
| Sauer, S | 1 |
| Edwards, JH | 1 |
| Alfaham, M | 1 |
| Fifield, R | 1 |
| Philpot, C | 1 |
| Clement, MJ | 1 |
| Goodchild, MC | 1 |
| Tortorano, AM | 4 |
| Pagano, A | 1 |
| Vigevani, GM | 1 |
| Gubertini, G | 1 |
| Cristina, S | 2 |
| Assaisso, ML | 1 |
| Suter, F | 1 |
| Farina, C | 1 |
| Minetti, B | 1 |
| Hanson, LH | 2 |
| Roesler, J | 1 |
| Scher, RK | 1 |
| Barnett, JM | 1 |
| Meunier, F | 1 |
| Impens, N | 1 |
| De Greve, J | 1 |
| De Beule, K | 2 |
| Meysman, M | 1 |
| De Beuckelaere, S | 1 |
| Schandevyl, W | 1 |
| Faggian, G | 1 |
| Livi, U | 1 |
| Bortolotti, U | 1 |
| Mazzucco, A | 1 |
| Stellin, G | 1 |
| Chiominto, B | 1 |
| Vivani, MA | 1 |
| Gallucci, V | 1 |
| Langer, M | 1 |
| Almaviva, M | 1 |
| Negri, C | 1 |
| Scoccia, S | 1 |
| De Maria, R | 1 |
| Fiocchi, R | 1 |
| Ferrazzi, P | 1 |
| Neijens, HJ | 1 |
| Frenkel, J | 1 |
| de Muinck Keizer-Schrama, SM | 1 |
| Dzoljic-Danilovic, G | 1 |
| Meradji, M | 1 |
| van Dongen, JJ | 1 |
| Elliott, JA | 1 |
| Cumming, D | 1 |
| Villard, C | 1 |
| Lacroix, C | 1 |
| Rabot, MH | 1 |
| Rovira, JC | 1 |
| Jacquemin, JL | 1 |
| De Laurenzi, A | 1 |
| Sharp, NJ | 2 |
| Sullivan, M | 2 |
| Khan, R | 1 |
| Longman, LP | 1 |
| Martin, MV | 1 |
| Thomas, PA | 1 |
| Abraham, DJ | 1 |
| Kalavathy, CM | 1 |
| Rajasekaran, J | 1 |
| Schattenberg, A | 1 |
| De Vries, F | 1 |
| De Witte, T | 1 |
| Cohen, O | 1 |
| Donnelly, JP | 1 |
| De Doncker, P | 1 |
| Cauwenbergh, G | 2 |
| Koster, M | 1 |
| Legendre, R | 1 |
| Blatchford, N | 1 |
| Daunas, J | 1 |
| Chwetzoff, E | 1 |
| Ackerbauer, H | 1 |
| Meingassner, JG | 1 |
| Mieth, H | 1 |
| Ahrens, J | 1 |
| Troke, PF | 1 |
| Andrews, RJ | 1 |
| Marriott, MS | 1 |
| Richardson, K | 1 |
| Woenstenborghs, R | 1 |
| Davies, SP | 1 |
| Webb, WJ | 1 |
| Patou, G | 1 |
| Murray, WK | 1 |
| Le, CT | 1 |
| Dennis, M | 1 |
| Shale, DJ | 1 |
| Faux, JA | 1 |
| Lane, DJ | 1 |
| Meyer, RD | 1 |
| Kwong, YL | 1 |
| Yu, YL | 1 |
| Chan, FL | 1 |
| Lam, KS | 1 |
| Woo, E | 1 |
| Huang, CY | 1 |
| Ichise, K | 1 |
| Tanio, T | 1 |
| Saji, I | 1 |
| Okuda, T | 1 |
| Bremard, C | 1 |
| Huu Trong, P | 1 |
| Vilmer, E | 1 |
| Komadina, TG | 1 |
| Wilkes, TD | 1 |
| Shock, JP | 1 |
| Ulmer, WC | 1 |
| Jackson, J | 1 |
| Bradsher, RW | 1 |
| Ishibashi, Y | 1 |
| Roudebush, P | 1 |
| Schaffner, A | 1 |
| Frick, PG | 1 |
| Torres, MA | 1 |
| Mohamed, J | 1 |
| Cavazos-Adame, H | 1 |
| Martinez, LA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| AMBINEB: Clinical Trial to Evaluate Tolerance and Safety of Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis in Patients With Acute Myeloid Leukemia and Allogeneic Haematopoietic Progenitor Cell Transplant (A[NCT00391014] | Phase 2 | 150 participants (Anticipated) | Interventional | 2006-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for ketoconazole and Aspergillosis
| Article | Year |
|---|---|
Improved outcome of zygomycosis in patients with hematological diseases?
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspe | 2004 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C | 1983 |
[Chemotherapy of aspergillus lung disease].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Flucytosine; Humans; Im | 1983 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidia | 1995 |
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Cand | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top | 1995 |
[Rapid increase in the incidence of respiratory aspergillosis. Improved diagnosis and more aggressive treatment for better prognosis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Incidence; Itraconazole; Ketoconazole; Lung D | 1992 |
[Primary Aspergillus endocarditis. Apropos of a case and review of the international literature].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; | 1992 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomy | 1992 |
Treatment and developmental therapeutics in aspergillosis. 2. Azoles and other antifungal drugs.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Azoles; Clotrim | 1992 |
[Semi-invasive aspergillosis with involvement of the thoracic wall cured by itraconazole].
Topics: Antifungal Agents; Aspergillosis; Carcinoma, Bronchogenic; Humans; Itraconazole; Ketoconazole; Lung | 1990 |
[Systemic mycotic infections].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; | 1990 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
Mycotic pneumonias.
Topics: Amphotericin B; Animals; Aspergillosis; Blastomycosis; Cat Diseases; Cats; Coccidioidomycosis; Crypt | 1985 |
10 trials available for ketoconazole and Aspergillosis
| Article | Year |
|---|---|
A controlled study to determine the efficacy of Loxostylis alata (Anacardiaceae) in the treatment of aspergillus in a chicken (Gallus domesticus) model in comparison to ketoconazole.
Topics: Anacardiaceae; Animals; Antifungal Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Ch | 2012 |
Treatment and prevention of oropharyngeal candidiasis.
Topics: Adolescent; Adult; Aged; Aspergillosis; Candidiasis; Child; Child, Preschool; Clinical Trials as Top | 1984 |
Prophylaxis of fungal infections in neutropenic cancer patients.
Topics: Agranulocytosis; Amphotericin B; Aspergillosis; Candidiasis; Clinical Trials as Topic; Humans; Ketoc | 1983 |
Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease.
Topics: Administration, Oral; Aspergillosis; Child; Child, Preschool; Female; Follow-Up Studies; Granulomato | 1994 |
Itraconazole in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Humans; Itraconazole; Ketoconazole; M | 1992 |
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Candidiasis; Drug Therapy, Combination; Female | 1991 |
[Imidazoles in the treatment of ocular mycoses].
Topics: Administration, Oral; Aspergillosis; Candidiasis; Eye Infections, Fungal; Humans; Ketoconazole; Opht | 1991 |
Itraconazole therapy in aspergillosis: study in 49 patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Enceph | 1990 |
The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987).
Topics: Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Clinical Trials as Topic; | 1988 |
Trial of ketoconazole in non-invasive pulmonary aspergillosis.
Topics: Adult; Aged; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Clinica | 1987 |
108 other studies available for ketoconazole and Aspergillosis
| Article | Year |
|---|---|
[Hydrocephaly resulting from thrombophlebitis of the superior sagittal sinus due to osteitis of the cranial vault caused by Aspergillus fumigatus in an immunocompetent patient].
Topics: Adult; Anticoagulants; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Heparin, Low-Molecul | 2018 |
Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Chronic Disease; Delayed Diagnosis; Diagnostic | 2015 |
Infectious keratitis caused by Aspergillus tubingensis.
Topics: Administration, Oral; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Transplantation; | 2009 |
Primary cutaneous aspergillosis.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Antifungal Agents; Aspergillosis; Aspergillus | 2010 |
Nonhealing scalp wound infected with Aspergillus niger in an elderly patient.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus niger; Bridged Bicyclo Compounds, H | 2011 |
Fungal infection of sutureless self-sealing incision for cataract surgery.
Topics: Aged; Aged, 80 and over; Amphotericin B; Aspergillosis; Candidiasis; Corneal Ulcer; Drug Therapy, Co | 2003 |
Paranasal sinus aspergillosis: its categorization to develop a treatment protocol.
Topics: Adolescent; Adult; Aged; Algorithms; Antifungal Agents; Aspergillosis; Child; Female; Humans; Itraco | 2004 |
Chemosensitization prevents tolerance of Aspergillus fumigatus to antimycotic drugs.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzaldehydes; Catechols; C | 2008 |
Itraconazole, a new triazole that is orally active in aspergillosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Itraconazole; Ketocona | 1984 |
Ketoconazole and fungal sinusitis.
Topics: Adolescent; Aspergillosis; Aspergillus fumigatus; Humans; Ketoconazole; Male; Maxillary Sinus; Sinus | 1984 |
Miconazole therapy for keratomycosis.
Topics: Adult; Aged; Aspergillosis; Candidiasis; Corneal Diseases; Female; Humans; Imidazoles; Keratitis; Ke | 1981 |
[Ketoconazole in the treatment of pulmonary aspergillosis and aspergilloma: mycological observations (author's transl)].
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus | 1982 |
[Fungal rhinitis in the dog. Diagnosis and therapy].
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Dog Diseases; Dogs; Female; Imidazoles; Ketoconazole; | 1982 |
Treatment of mycoses in cancer patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Oral; Drug Therapy, Comb | 1983 |
Ketoconazole: a new imidazole antifungal agent has both prophylactic potential and therapeutic efficacy in keratomycosis of rabbits.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Imidazoles; Keratitis; Ketoconazole; | 1982 |
Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergi | 1982 |
Treatment of fungal infections in the bones and joints with ketoconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Bone Diseases; Child; Coccidioidomycosis; Humans; Imidazole | 1983 |
Pseudallescheria boydii infection after bone marrow transplantation.
Topics: Adult; Antifungal Agents; Ascomycota; Aspergillosis; Bone Marrow Transplantation; Diagnosis, Differe | 1983 |
Treatment of experimental murine aspergillosis with BAY n7133.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dose-Response Rela | 1983 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergill | 1984 |
[Aspergillosis of the larynx].
Topics: Adult; Aspergillosis; Aspergillus fumigatus; Female; Follow-Up Studies; Humans; Itraconazole; Ketoco | 1995 |
Ketoconazole in aspergillosis.
Topics: Aspergillosis; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Ketoconazole; Ki | 1994 |
Treatment of pulmonary aspergilloma by endoscopic intracavitary instillation of ketoconazole.
Topics: Adult; Aspergillosis; Aspergillus flavus; Bronchoscopy; Humans; Instillation, Drug; Ketoconazole; Lu | 1993 |
Interaction of itraconazole and digoxin.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Digoxin; Drug Interactions; Half-Life | 1993 |
Complete eradication of Aspergillus fumigatus from the lung in an immunocompromised patient by oral itraconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; | 1993 |
Renal aspergilloma in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspe | 1993 |
Successful treatment of concomitant pulmonary nocardiosis and aspergillosis in an immunocompromised renal patient.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclophosphamide; Drug Therapy, Comb | 1993 |
Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Bone Marrow Transplantat | 1993 |
Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Female; Humans | 1993 |
Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; A | 1993 |
Endoscopic instillation of fungicide to treat aspergilloma.
Topics: Antifungal Agents; Aspergillosis; Bronchoscopy; Humans; Instillation, Drug; Ketoconazole; Lung Disea | 1996 |
Invasive Aspergillus tympanomastoiditis in an immunocompetent patient.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Ketoconazol | 1997 |
Multifocal Aspergillus terreus discospondylitis in two German shepherd dogs.
Topics: Amoxicillin; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Cervical Vertebrae; Clavulanic | 1996 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
[Aspergillosis of the paranasal sinuses].
Topics: Adult; Antifungal Agents; Aspergillosis; Endoscopy; Humans; Ketoconazole; Maxillary Sinus; Tomograph | 1998 |
Aspergillosis of the larynx: a report of 8 cases.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Diagnosis, Differential; Female; Humans; Ketoc | 1997 |
[Dorsal cord compression by aspergilloma. Apropos of a case].
Topics: Abscess; Adult; Antifungal Agents; Aspergillosis; Diagnosis, Differential; Discitis; Epidural Space; | 1997 |
Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Cryptococcosis; Cryptococcu | 1992 |
Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Female; | 1992 |
The evaluation of therapeutic responses in experimental keratomycosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count | 1992 |
Fungal scleritis after cataract surgery. Successful outcome using itraconazole.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus flavus; Cataract Extraction; Eye | 1992 |
Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1992 |
Treatment with itraconazole of penguins suffering from aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Birds; Itraconazole; Ketoconazole; Lung Di | 1992 |
[Sphenoid sinus aspergillosis presenting abducens nerve palsy and visual field impairment; a case report].
Topics: Abducens Nerve; Aged; Antifungal Agents; Aspergillosis; Cranial Nerve Diseases; Female; Fluconazole; | 1992 |
[Itraconazole++-induced neurotoxicity].
Topics: Aged; Antifungal Agents; Aspergillosis; Cerebellar Diseases; Humans; Itraconazole; Ketoconazole; Lun | 1992 |
Diagnosis of avian aspergillosis and treatment with itraconazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Birds; Itraconazole | 1992 |
Possible failure of itraconazole in preventing fungal infection in a neutropenic leukaemia patient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Aspergillus niger; Humans; Itraconazole; Ke | 1992 |
Aspergillus intraabdominal abscess after liver transplantation successfully treated with itraconazole.
Topics: Abdomen; Abscess; Adult; Antifungal Agents; Aspergillosis; Female; Humans; Itraconazole; Ketoconazol | 1992 |
Digoxin toxicity associated with itraconazole therapy.
Topics: Aged; Antifungal Agents; Aspergillosis; Digoxin; Drug Interactions; Female; Humans; Itraconazole; Ke | 1992 |
[The use of itraconazole in liver transplantation].
Topics: Antifungal Agents; Aspergillosis; Humans; Itraconazole; Ketoconazole; Liver Transplantation; Lung Di | 1992 |
Aspergillus-induced discitis. A role for itraconazole in therapy?
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Discitis; Humans; It | 1992 |
[Chronic aspergillosis in familial chronic granulomatosis].
Topics: Adult; Antifungal Agents; Aspergillosis; Dermatomycoses; Fingers; Granulomatous Disease, Chronic; Hu | 1992 |
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation, Precl | 1992 |
Necrotizing bronchial aspergillosis in a patient receiving neoadjuvant chemotherapy for non-small cell lung carcinoma.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus | 1991 |
Itraconazole and aspergilloma.
Topics: Antifungal Agents; Aspergillosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1991 |
[Aspergillosis with involvement of the thoracic wall].
Topics: Antifungal Agents; Aspergillosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Pneumon | 1991 |
Treatment of postoperative Aspergillus fumigatus spondylodiscitis with itraconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Debridement; Dis | 1991 |
Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Biopsy; Bronchi; Bronchitis; Female; Humans; Itraconazole; | 1991 |
Control of proven pulmonary and suspected CNS aspergillus infection with itraconazole in a patient with chronic granulomatous disease.
Topics: Antifungal Agents; Aspergillosis; Brain Diseases; Child; Granulomatous Disease, Chronic; Humans; Itr | 1991 |
[The treatment of pulmonary aspergilloma with itraconazole].
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Drug Evaluation; Female; Humans; Itraconazole; Ketoco | 1991 |
Treatment of deep mycoses with itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Antitubercular Agents; Aspergillosis; Child; Chromoblastom | 1991 |
[Mycoses as opportunistic infections in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; H | 1991 |
Treatment of pulmonary aspergilloma with itraconazole.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Immunog | 1991 |
Effect of ketoconazole on external otitis.
Topics: Adult; Aged; Aspergillosis; Cresols; Humans; Ketoconazole; Middle Aged; Otitis Externa | 1991 |
Amphotericin-resistant aspergillus osteomyelitis controlled by itraconazole.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Micr | 1990 |
Itraconazole and anti-tuberculosis drugs.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Itraconazole; Ketoconazole; Lung Di | 1990 |
Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Ulcer; Disease Model | 1990 |
Neosartorya fischeri var fischeri (Wehmer) Malloch and Cain 1972 (anamorph: Aspergillus fischerianus Samson and Gams 1985) as a cause of mycotic keratitis.
Topics: Aspergillosis; Aspergillus; Cornea; Eye Enucleation; Eye Infections, Fungal; Humans; Keratitis; Keto | 1990 |
Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease.
Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Chromatography, High Pressure Liqu | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Crypto | 1990 |
False aneurysm infected by Aspergillus fumigatus: an unusual complication of aortofemoral bypass graft.
Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Aorta, Abdominal; Aspergillosis; Aspergillus | 1990 |
Cyclosporine and itraconazole interaction in heart and lung transplant recipients.
Topics: Aspergillosis; Coccidiosis; Cyclosporins; Drug Interactions; Heart Transplantation; Heart-Lung Trans | 1990 |
[Aspergillus mastoiditis in infected granulomatosis--a case report].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Combined Modality Therapy; Granuloma | 1990 |
Sequential serological responses to Aspergillus fumigatus in patients with cystic fibrosis. Use of antigen 'stretching' to delineate IgG and IgE activity.
Topics: Adolescent; Adult; Antibodies, Fungal; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Child | 1990 |
European experience with itraconazole in systemic mycoses.
Topics: Antifungal Agents; Aspergillosis; Child; Cryptococcosis; Drug Administration Schedule; Humans; Itrac | 1990 |
Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; | 1990 |
Treatment of invasive Aspergillus infection with itraconazole.
Topics: Antifungal Agents; Aspergillosis; Humans; Infant; Intestinal Absorption; Itraconazole; Ketoconazole; | 1990 |
Successful treatment of Aspergillus flavus onychomycosis with oral itraconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Female; Humans; Itraconazole; Ketoconazole; Mi | 1990 |
Oral treatment with itraconazole of aspergilloma in cavitary lung cancer.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Carcinoma, Small Cell; Humans; Itraconazole | 1990 |
Itraconazole therapy for acute invasive pulmonary aspergillosis in heart transplantation.
Topics: Acute Disease; Adult; Aspergillosis; Cyclosporins; Heart Transplantation; Humans; Itraconazole; Keto | 1989 |
Experience with itraconazole in cryptococcosis and aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Cryptoc | 1989 |
Treatment of invasive aspergillosis with itraconazole.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Drug Evalu | 1989 |
Invasive Aspergillus infection in chronic granulomatous disease: treatment with itraconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Granulomatous Disease, Chronic; Human | 1989 |
Chronic necrotising pulmonary aspergillosis treated with itraconazole.
Topics: Antifungal Agents; Aspergillosis; Chronic Disease; Humans; Itraconazole; Ketoconazole; Lung; Lung Di | 1989 |
[Severe Aspergillus keratomycosis treated with itraconazole per os].
Topics: Administration, Oral; Adult; Anterior Chamber; Antifungal Agents; Aspergillosis; Aspergillus fumigat | 1989 |
Aspergillosis in a cardiac transplant patient successfully treated with itraconazole.
Topics: Aspergillosis; Aspergillus fumigatus; Heart Transplantation; Humans; Itraconazole; Ketoconazole; Mal | 1989 |
Use of ketoconazole in the treatment of canine nasal aspergillosis.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Dog Diseases; Dogs; Dose-Response Relationship, Drug; | 1989 |
Clinical and experimental mycotic corneal ulcer caused by Aspergillus fumigatus and the effect of oral ketoconazole in the treatment.
Topics: Administration, Oral; Animals; Aspergillosis; Aspergillus fumigatus; Child; Corneal Ulcer; Disease M | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1987 |
A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Endocarditis; Fluc | 1987 |
[Itraconazole in the treatment of deep mycoses].
Topics: Antifungal Agents; Aspergillosis; Drug Evaluation; Humans; Itraconazole; Ketoconazole; Lung Diseases | 1987 |
Oral itraconazole therapy for mycotic keratitis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Child; Female; Fusarium; Humans; Itraconazole; | 1988 |
Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung.
Topics: Adult; Amphotericin B; Aspergillosis; Bone Marrow Transplantation; Female; Humans; Itraconazole; Ket | 1988 |
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, An | 1985 |
Itraconazole treatment of murine aspergillosis.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Itraconazole; Ketoconazole; Male; Mic | 1985 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus | 1987 |
Experience with itraconazole in deep mycoses in northern Italy.
Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Itraconazole; Ketoconazole; Sporotrichosis | 1987 |
Renal aspergilloma--a case illustrating the problems of medical therapy.
Topics: Amphotericin B; Aspergillosis; Female; Flucytosine; Humans; Ketoconazole; Kidney Diseases; Middle Ag | 1987 |
Adrenal mass in an immunocompromised man.
Topics: Abscess; Adrenal Gland Diseases; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Diagnosis, Di | 1988 |
Treatment of canine nasal aspergillosis with systemic ketoconazole and topical enilconazole.
Topics: Administration, Topical; Animals; Aspergillosis; Aspergillus fumigatus; Dog Diseases; Dogs; Drug The | 1986 |
High dose ketoconazole in the treatment of cerebral aspergilloma.
Topics: Adult; Amphotericin B; Aspergillosis; Brain Diseases; Drug Therapy, Combination; Female; Flucytosine | 1987 |
Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Vulvovaginal; Female; Guinea Pi | 1986 |
[Aspergillus infection and chronic septic granulomatosis].
Topics: Adolescent; Amphotericin B; Aspergillosis; Child; Child, Preschool; Female; Granulomatous Disease, C | 1985 |
Treatment of Aspergillus fumigatus keratitis in rabbits with oral and topical ketoconazole.
Topics: Administration, Oral; Administration, Topical; Animals; Aspergillosis; Drug Evaluation, Preclinical; | 1985 |
Treatment of Aspergillus fumigatus keratitis in rabbits with oral and topical ketoconazole.
Topics: Administration, Oral; Administration, Topical; Animals; Aspergillosis; Aspergillus fumigatus; Kerati | 1985 |
The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis.
Topics: Amphotericin B; Animals; Aspergillosis; Disease Models, Animal; Female; Humans; In Vitro Techniques; | 1985 |
Topical ketoconazole for fungal keratitis.
Topics: Administration, Topical; Adult; Aspergillosis; Female; Fusarium; Humans; Keratitis; Ketoconazole; Ma | 1985 |